Afficher la notice abrégée

dc.rights.licenseopenen_US
dc.contributor.authorPROIETTO, D.
dc.contributor.authorDALLAN, B.
dc.contributor.authorGALLERANI, E.
dc.contributor.authorALBANESE, V.
dc.contributor.authorLLEWELLYN-LACEY, S.
dc.contributor.authorPRICE, D.A.
hal.structure.identifierImmunology from Concept and Experiments to Translation = Immunologie Conceptuelle, Expérimentale et Translationnelle [ImmunoConcept]
dc.contributor.authorAPPAY, Victor
dc.contributor.authorPACIFICO, S.
dc.contributor.authorCAPUTO, A.
dc.contributor.authorNICOLI, F.
dc.contributor.authorGAVIOLI, R.
dc.date.accessioned2024-09-19T14:37:41Z
dc.date.available2024-09-19T14:37:41Z
dc.date.issued2023-01
dc.identifier.issn2076-393Xen_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/201698
dc.description.abstractEnAge-related changes in the immune system are thought to underlie the vulnerability of elderly individuals to emerging viral diseases, such as coronavirus disease 2019 (COVID-19). In this study, we used a fully validated in vitro approach to determine how age impacts the generation of de novo CD8+ T cell responses against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the causative agent of COVID-19. Our data revealed a generalized deficit in the ability of elderly individuals to prime the differentiation of naïve precursors into effector CD8+ T cells defined by the expression of interferon (IFN)-γ and the transcription factor T-bet. As a consequence, there was an age-related decline in the diversity of newly generated CD8+ T cell responses targeting a range of typically immunodominant epitopes derived from SARS-CoV-2, accompanied by an overall reduction in the expression frequency of IFN-γ. These findings have potential implications for the development of new strategies to protect the elderly against COVID-19.
dc.language.isoENen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.subject.enCD8+ T cells
dc.subject.enimmunosenescence
dc.subject.enSARS-CoV-2
dc.title.enAgeing Curtails the Diversity and Functionality of Nascent CD8+ T Cell Responses against SARS-CoV-2
dc.typeArticle de revueen_US
dc.identifier.doi10.3390/vaccines11010154en_US
dc.subject.halSciences du Vivant [q-bio]/Immunologieen_US
dc.identifier.pubmed36679999en_US
bordeaux.journalVaccinesen_US
bordeaux.volume11en_US
bordeaux.hal.laboratoriesImmunoConcEpT - UMR 5164en_US
bordeaux.issue1en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionCNRSen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-04702955
hal.version1
hal.date.transferred2024-09-19T14:37:44Z
hal.popularnonen_US
hal.audienceInternationaleen_US
hal.exporttrue
dc.rights.ccCC BYen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Vaccines&rft.date=2023-01&rft.volume=11&rft.issue=1&rft.eissn=2076-393X&rft.issn=2076-393X&rft.au=PROIETTO,%20D.&DALLAN,%20B.&GALLERANI,%20E.&ALBANESE,%20V.&LLEWELLYN-LACEY,%20S.&rft.genre=article


Fichier(s) constituant ce document

Thumbnail
Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée